Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2011-04-21 | Dr. Dilly received an M.B.B.S. from the University of London and a Ph.D. in Cardiac Physiology. Dr. Dilly brings medical expertise and significant drug development experience to our Board. |
| 2012-04-25 | Dr. Dilly received an M.B.B.S. from the University of London and a Ph.D. in Cardiac Physiology. Dr. Dilly brings medical expertise and significant drug development experience to our Board. |
| 2013-04-25 | Dr. Dilly received an M.B.B.S., the equivalent of an M.D. in the U.S., from the University of London in the U.K. and a Ph.D. in cardiac physiology from University of London in 1988. Dr. Dilly brings medical expertise and significant drug development experience to our Board. |
| 2014-03-11 | Dr. Dilly received an M.B.B.S., the equivalent of an M.D. in the U.S., from the University of London in the U.K. and a Ph.D. in cardiac physiology from University of London in 1988. Dr. Dilly brings medical expertise and significant drug development experience to our Board. |
| 2015-04-28 | Dr. Dilly brings medical expertise and significant drug development experience to our Board. |
| 2016-04-25 | Dr. Dilly received an M.B.B.S. and a Ph.D. in cardiac physiology. Dr. Dilly brings medical expertise and significant drug development experience. |
| 2017-04-25 | Dr. Dilly has been closely associated with the development and launch of marketed drugs for many therapeutic areas. He received an M.B.B.S. and a Ph.D. in cardiac physiology. |
| 2018-04-24 | In 1982 Dr. Dilly received an M.B.B.S., the equivalent of an M.D. in the United States, from the University of London in the U.K. and a Ph.D. in cardiac physiology from University of London in 1988. |
| 2019-04-25 | In 1982 Dr. Dilly received an M.B.B.S., the equivalent of an M.D. in the United States, from the University of London in the U.K. and a Ph.D. in cardiac physiology from University of London in 1988. |
Data sourced from SEC filings. Last updated: 2025-10-11